Previously treated cases tested for RR-/MDR-TB in Mozambique
Mozambique: Previously treated cases tested for RR-/MDR-TB was 25.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Mozambique, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Mozambique stood at 25.0%.
Compared with earlier readings it is down 70.6% on the previous year and up 66.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Mozambique peaked at 100.0% in 2019 and was at its lowest, 5.4%, in 2012.
That places Mozambique 164th out of 180 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Mozambique, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 16.0% | — |
| 2006 | 8.2% | -48.8% |
| 2007 | 18.0% | +119.5% |
| 2008 | 16.0% | -11.1% |
| 2009 | 5.9% | -63.1% |
| 2010 | 6.2% | +5.1% |
| 2011 | 10.0% | +61.3% |
| 2012 | 5.4% | -46.0% |
| 2013 | 8.8% | +63.0% |
| 2014 | 15.0% | +70.5% |
| 2015 | 31.0% | +106.7% |
| 2016 | 55.0% | +77.4% |
| 2017 | 6.4% | -88.4% |
| 2018 | 66.0% | +931.2% |
| 2019 | 100.0% | +51.5% |
| 2020 | 70.0% | -30.0% |
| 2021 | 100.0% | +42.9% |
| 2022 | 82.0% | -18.0% |
| 2023 | 85.0% | +3.7% |
| 2024 | 25.0% | -70.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 12.8% | 5.9% | 18.0% | 5 |
| 2010s | 30.4% | 5.4% | 100.0% | 10 |
| 2020s | 72.4% | 25.0% | 100.0% | 5 |
Countries ranked near Mozambique
- 161 Guinea 29.0% compare
- 161 North Macedonia 29.0% compare
- 163 Trinidad and Tobago 27.0% compare
- 165 Cape Verde 20.0% compare
- 166 Djibouti 17.0% compare
- 167 Solomon Islands 9.1% compare
More health data for Mozambique
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.16 % change on previous year (2090)
- Heat deaths vs projected death rates 869.7 (2090)
- Un projection of annual infant deaths 18,288 (2100)
- Population ages 15-64, male, annual growth rate 3.75 % change on previous year (2025)
- Population ages 15-64, male, per unit of GDP 0.0004 units per US$ of GDP (2025)
- Population ages 15-64, male, per capita 0.2549 units per person (2025)
- Population ages 15-64, total, annual growth rate 3.53 % change on previous year (2025)
- Population ages 15-64, total, per unit of GDP 0.0008 units per US$ of GDP (2025)
- Population ages 15-64, total, per capita 0.531 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Mozambique?
- Previously treated cases tested for rr-/mdr-tb in Mozambique was 25.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Mozambique?
- The highest recorded value was 100.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Mozambique?
- The lowest recorded value was 5.4% in 2012.
- How does Mozambique rank for previously treated cases tested for rr-/mdr-tb?
- Mozambique ranks 164th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Mozambique?
- Over the last ten years it is up 66.7%. The long-run trend across the full record is volatile.
- Where does this Mozambique data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).